COVID Drug 'Virafin' By Zydus To Cost Rs 11,995 Per Dose
Pharmaceutical giant Zydus Cadila has announced that a dose of its COVID-19 drug 'Virafin' will cost Rs 11,995. The company has claimed that Virafin will lessen the need for oxygen in COVID-19 patients. The drug was earlier approved by the Drug Controller General of India on April 23 for treatment of mild COVID-19 cases. Meanwhile, Zydus is also in the process to launch its three-dose COVID-19 vaccine Zy-CoV-D.